ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 722,000 shares, an increase of 52.1% from the March 31st total of 474,600 shares. Approximately 3.2% of the shares of the stock are short sold. Based on an average trading volume of 638,000 shares, the short-interest ratio is presently 1.1 days.
Wall Street Analyst Weigh In
Separately, HC Wainwright raised their price objective on ASP Isotopes from $5.25 to $5.50 and gave the stock a “buy” rating in a research report on Wednesday, April 17th.
Check Out Our Latest Stock Analysis on ASPI
ASP Isotopes Stock Up 1.8 %
ASP Isotopes (NASDAQ:ASPI – Get Free Report) last posted its earnings results on Wednesday, April 10th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.43 million during the quarter. On average, equities analysts anticipate that ASP Isotopes will post -0.11 earnings per share for the current fiscal year.
Insider Activity at ASP Isotopes
In related news, Director Robert John Andrew Ryan bought 15,596 shares of the company’s stock in a transaction on Monday, January 29th. The stock was bought at an average cost of $2.35 per share, for a total transaction of $36,650.60. Following the acquisition, the director now directly owns 537,055 shares in the company, valued at $1,262,079.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 26.30% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in ASP Isotopes stock. HTLF Bank purchased a new stake in ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 78,538 shares of the company’s stock, valued at approximately $141,000. HTLF Bank owned 0.16% of ASP Isotopes as of its most recent SEC filing. 16.80% of the stock is currently owned by institutional investors and hedge funds.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
See Also
- Five stocks we like better than ASP Isotopes
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- MarketBeat Week in Review – 4/22 – 4/26
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Stocks Leading the U.S. Agriculture Comeback
- Why Are Stock Sectors Important to Successful Investing?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.